A Phase 1 Study of S-637880 - Investigation of the effects of multiple doses, and the drug-drug interaction with midazolam
Latest Information Update: 29 Dec 2021
At a glance
- Drugs S-637880 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions
- Sponsors Shionogi Pharma
- 29 Dec 2021 New trial record